Drug Profile
Nitroglycerin transdermal - Nometics/Queen's University
Alternative Names: Glyceryl trinitrate - Nometics; GTN - Nometics; NOVadeLatest Information Update: 02 Jan 2023
Price :
$50
*
At a glance
- Originator Queens University
- Class Antineoplastics; Erectile dysfunction therapies; Heart failure therapies; Ischaemic heart disorder therapies; Nitro compounds; Organic nitrates; Small molecules; Sugar alcohols; Vasodilators
- Mechanism of Action Guanylate cyclase stimulants; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Colorectal cancer; Non-small cell lung cancer
- Discontinued Prostate cancer
Most Recent Events
- 02 Jan 2023 Discontinued - Phase-III for Prostate cancer (Recurrent) in Canada (Transdermal)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Colorectal-cancer in Canada (Transdermal, Patch)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Non-small-cell-lung-cancer in Canada (Transdermal, Patch)